Clinical trial
The Role of Adaptive Immune Responses to Mycoplasma Pneumoniae in Pathogenesis and Diagnosis of Community-acquired Pneumonia (CAP) in Children: an Observational Single-center Study (myCAP Study)
NCT03613636 is registered in ClinicalTrials.gov with University Children's Hospital, Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Adaptive Immune Responses to Mycoplasma Pneumoniae in Pathogenesis and Diagnosis of Community-acquired Pneumonia (CAP) in Children: an Observational Single-center Study (myCAP Study)
- Lead sponsor
- University Children's Hospital, Zurich
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2016
- Completion date
- October 31, 2020
- Enrollment
- 490 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
antibody-secreting cells, childhood pneumonia, diagnosis, enzyme-linked immunospot (elispot), mycoplasma pneumonia